CClinicalTrials.gg
CompletedNCT05612737Updated Nov 10, 2022

Evaluation of a Novel Horizontal Ridge Augmentation Technique in Dentistry

An interventional study of Horizontal bone augmentation in Bone Augmentation and Bone Loss, Alveolar, sponsored by Semmelweis University. Completed at 1 site in Hungary. Open to participants aged 18 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2022-11-10.

Sponsored by Semmelweis University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 3 years after the study started (first participant enrolled Oct 2019, registered Oct 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
5
Allocation
Not applicable
Ages
18 Years to 70 Years
Sex
All
01

Study summary

This case series aimed to assess the efficacy of a novel horizontal ridge augmentation modality using histomorphometry and Raman spectroscopy. Combinations of "sticky bone" and tenting screws without autologous bone were used as augmentative materials.

Read the detailed description

This case series aimed to evaluate the efficacy of the horizontal augmentation technique using the tenting screw technique with "sticky bone." The main aim was to determine whether this method provides similar results to the gold standard GBR or autologous onlay block grafts. In addition, the validity of neglecting autologous graft and its possible substitution with growth factor concentrate were examined. The novelty of this study is that no human histological examination of the described procedure has been conducted previously. It is hypothesized that the "stick bone" containing autologous platelet concentrate can substitute the use of particulate autologous bone graft in these type of procedures. In this prospective case series study five patients were enrolled and treated with the same type of bone augmentation in order to increase the alveolar ridge in the horizontal dimension with the previously mentioned technique. After 5 months of healing a second reentry surgery was performed in order to harvest the bone core for biopsy, to asses the chemical compound composition by Raman spectroscopy in vivo and to place the dental implants at the same time. Newly formed tissues were evaluated clinically during reentry, radiologically by CBCT acquisition, qualitatively and quantitatively by histological processing and physicochemically by means of Raman spectroscopy.

02

Conditions studied

  • Bone Augmentation
  • Bone Loss, Alveolar

Browse trials for

Keywords

  • platelet concentrate
  • horizontal bone augmentation
  • "sticky bone"
  • Histology
  • Raman spectroscopy
03

In context

Alveolar Bone Loss

297 studies on the registry are indexed under Alveolar Bone Loss; 76 are open to participants now.

This study's enrollment of 5 is below the median of 25 across 254 interventional studies indexed under Alveolar Bone Loss.

Browse Alveolar Bone Loss studies →

Lead sponsor

Semmelweis University is the lead sponsor of 136 studies on the registry; 54 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 70 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • one or more missing teeth in the jaw's posterior area, where horizontal bone width is ≤5 mm.
  • no deficiency in the vertical dimension.
  • The tooth must have been removed ≥4 months before augmentation.
  • The patient should understand the nature of the research and be compliant in study-related activities

Exclusion criteria

Exclusion Criteria:

  • pregnancy
  • smoking
  • uncontrolled diabetes
  • systemic diseases or drug consumption affecting bone metabolism, and clinically relevant osteoporosis
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
5 participants (actual)

Study arms

  • Experimental
    "Sticky bone" and tenting screw

    Procedure: Horizontal bone augmentation

Interventions

  • ProcedureHorizontal bone augmentation

    After taking six 9 mL tubes of blood from the patient, advanced (A-PRF) and liquid (S-PRF) PRFs were prepared. A-PRF was chopped, added to the xenogeneic bone substitute (THE Graft; Purgo Biologics Inc.), and then impregnated with the liquid S-PRF, which enabled the particulate bone substitute to become moldable and turned into a block ("sticky bone"). After local anesthesia, a midcrestal incision was made with one vertical releasing incision at the flap's mesial end. After full-thickness flap elevation, a periosteal releasing incision was made at the flap's apical portion. The alveolar bone was decorticalized on the buccal aspect with surgical burs. Next, the prepared "bonded" graft matrix was adapted to the ridge. Then, tenting screws (Pro-fix; Osteogenics) were placed to maintain the periosteum in an elevated and tension-free position The bone augmentation material was covered with A-PRF membranes. Finally, tension-free wound closure was performed.

06

What researchers measure

Primary outcomes

  1. Amount of newly formed bone by means of histomorphometry

    The percentage of newly formed bone of the augmented site within the biopsy

    Time frame: 5 months postoperatively

  2. Amount of graft material bone by means of histomorphometry

    The percentage of graft material (THE Graft; Purgo Biologics Inc.) of the augmented site within the biopsy

    Time frame: 5 months postoperatively

  3. Amount of soft tissue by means of histomorphometry

    The percentage of soft tissue of the augmented site within the biopsy

    Time frame: 5 months postoperatively

  4. The quality of the newly formed tissues by means of histology

    The descriptive analyses of the cells and tissue structure of the augmented site within the biopsy

    Time frame: 5 months postoperatively

Secondary outcomes

  1. In vivo spectroscopy analyses of the augmented site with a Raman spectrometer device

    Raman investigation (measuring wavelength in the range 300-1800 cm-1) highlights the peaks (Raman shift) for the main bone components (chemical groups and elements) in order to evaluate differences between bone tissue for the investigated patients. Differences in peaks intensity on raw spectra reflected the differences in the quantities of the chemical components for investigated specimens.

    Time frame: 5 months postoperatively

  2. CBCT analysis

    Horizontal bone volume gain (measured in mm) evaluated on pre- and postoperative CBCT-s.

    Time frame: 5 months postoperatively

  3. The clinical descriptive bone assessment of the augmented bone site

    The descriptive clinical assessment is a subjective evaluation of the augmented bone judged by the operator. The presence of possibly occuring non-integrated graft remnants can be assessed during reentry surgery.

    Time frame: 5 months postoperatively

  4. The clinical descriptive bone assessment of the augmented bone site

    The descriptive clinical assessment is a subjective evaluation of the augmented bone judged by the operator. The bleeding property of the newly formed bone after drilling the osteotomy for the implant can be assessed during reentry.

    Time frame: 5 months postoperatively

07

Study locations

1 site
  • Semmelweis University Department of Periodontology
    Budapest, 1088, Hungary
08

References and documents

Publications

  • Urban IA, Nagursky H, Lozada JL, Nagy K. Horizontal ridge augmentation with a collagen membrane and a combination of particulated autogenous bone and anorganic bovine bone-derived mineral: a prospective case series in 25 patients. Int J Periodontics Restorative Dent. 2013 May-Jun;33(3):299-307. doi: 10.11607/prd.1407. PubMed 23593623 ↗
  • Khoury F, Hanser T. Mandibular bone block harvesting from the retromolar region: a 10-year prospective clinical study. Int J Oral Maxillofac Implants. 2015 May-Jun;30(3):688-97. doi: 10.11607/jomi.4117. PubMed 26009921 ↗
  • Tan WL, Wong TL, Wong MC, Lang NP. A systematic review of post-extractional alveolar hard and soft tissue dimensional changes in humans. Clin Oral Implants Res. 2012 Feb;23 Suppl 5:1-21. doi: 10.1111/j.1600-0501.2011.02375.x. PubMed 22211303 ↗
  • Farias D, Caceres F, Sanz A, Olate S. Horizontal Bone Augmentation in the Posterior Atrophic Mandible and Dental Implant Stability Using the Tenting Screw Technique. Int J Periodontics Restorative Dent. 2021 Jul-Aug;41(4):e147-e155. doi: 10.11607/prd.5137. PubMed 34328475 ↗
  • Gheno E, Alves GG, Ghiretti R, Mello-Machado RC, Signore A, Lourenco ES, Leite PEC, Mourao CFAB, Sohn DS, Calasans-Maia MD. "Sticky Bone" Preparation Device: A Pilot Study on the Release of Cytokines and Growth Factors. Materials (Basel). 2022 Feb 16;15(4):1474. doi: 10.3390/ma15041474. PubMed 35208017 ↗
  • Ghanaati S, Booms P, Orlowska A, Kubesch A, Lorenz J, Rutkowski J, Landes C, Sader R, Kirkpatrick C, Choukroun J. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells. J Oral Implantol. 2014 Dec;40(6):679-89. doi: 10.1563/aaid-joi-D-14-00138. PubMed 24945603 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 10, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05612737
Lead sponsor
Semmelweis University
Collaborators
Purgo Biologics Inc., FORM-Lab
Responsible party
Pal Nagy (Assistant Professor, Semmelweis University) — Principal investigator
First posted
Nov 10, 2022
Start date
Oct 1, 2019
Primary completion
Apr 30, 2021
Completion
Oct 31, 2021
Last update
Nov 10, 2022

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion